glutathione in ovarian cancer a double-edged sword Cysteine metabolic circuitries: druggable targets The good, the bad, and
The good, the bad, and the iron: Ferroptosis and macrophages in ovarian cancer Glutathione in Ovarian Cancer: A Double Edged Sword Frontiers The strategic breakdown: CHAC enzymes as regulators of glutathione homeostasis and disease implications Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25



